🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
During the study, members of different online and offline communities will ...
Status
Unknown
Location
MEBO Research, Inc
Start Date
2021-01-05
Trial ID
NCT04832932
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
A longitudinal open-label study will include health professionals and patie...
Status
Unknown
Location
Federal University of Espirito Santo
Start Date
2021-01-15
Trial ID
NCT05133609
Treatments Being Tested
This project aims to monitor the side effects of COVID-19 vaccines worldwid...
Status
Recruiting
Location
American College of Physicians
Start Date
2021-04-01
Trial ID
NCT04834869
Treatments Being Tested
The AstraZeneca Study is a single-arm, open-label, interventional, Phase 3b...
Status
Completed
Location
Botswana Harvard Health Partnership
Start Date
2021-09-15
Trial ID
NCT05715944
Treatments Being Tested
COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus ...
Status
Unknown
Location
Institute of Liver & Biliary Sciences
Start Date
2021-03-19
Trial ID
NCT04794946
Treatments Being Tested
The aim of the study is to assess the safety, and immunogenicity of AZD2816...
Status
Completed
Location
Research Site
Start Date
2021-06-27
Trial ID
NCT04973449
The aim of this study is to assess the immunogenicity and safety of AZD1222...
Status
Terminated
Location
Research Site
Start Date
2022-01-31
Trial ID
NCT05057897
Treatments Being Tested
The aim of the study is to assess the safety, efficacy, and immunogenicity ...
Status
Completed
Location
Research Site
Start Date
2020-08-28
Trial ID
NCT04516746
The primary objective of the study is to measure the anti-SARS-CoV-2 neutra...
Status
Completed
Location
Hospital Fundación Tesai
Start Date
2022-07-09
Trial ID
NCT05426343
Treatments Being Tested